Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
H5N1 Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated), non-adjuvanted formulation
BIOLOGICAL
2 trials
Sponsors
Alachua Government Services, Inc.
Conditions
Influenza
Influenza, Avian
Phase 1
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
Completed
NCT01052402
Alachua Government Services, Inc.
Influenza, Avian
Start: 2009-12-31
End: 2012-11-30
Updated: 2015-10-09
Phase 3
H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older
Completed
NCT01774032
Alachua Government Services, Inc.
Influenza
Start: 2013-03-31
End: 2013-10-31
Updated: 2015-10-09
Related Papers
Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population
The Journal of Infectious Diseases
2013-09-16
32 citations